Activity Description
This self-guided course provides practical recommendations and guidance on what hematology/oncology practices can do to improve patient experience and outcomes before their patient reaches a transplant center for consultation for Hematopoietic Cell Transplantation (HCT).
Speakers
David Hermel, MD
Scripps Clinic
La Jolla, CA, USA
David Hermel, MD, has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Catherine Lee, MD
University of Utah, Huntsman Cancer Institute
Salt Lake City, UT, USA
Catherine Lee, MD, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Incyte Corporation, Kadmon, Kite Pharma
Research Grant: Incyte Corporation
Speakers’ Bureau: Kite Pharma
The following relationships have ended within the last 24 months: Advisory Board/Consultant: Bristol Myers Squibb, Fresenius Kabi
Accreditation and Disclosure Information
Target Audience
This activity is intended for community hematology/oncology practitioners including physicians, APPs, and nurses involved in the diagnosis of HCT-indicated diseases and essential for referral to a transplant center for HCT and cell therapy consultation.
Educational Objectives
After completing this activity, the participant should be better able to:
- Summarize tactics and resources for community hematology/oncology practices to successfully introduce transplant and cell therapy options to patients.
- Recommend early HLA typing and coordinated care to address barriers and delays to transplant.
- Review resources for insurance coverage, funding options, transportation, and caregiver solutions.
- Recommend use of transplant consultation timing guidelines.
Program Agenda
- Intro: A Sample Case
- Barriers to HCT
- Addressing Barriers and Expanding Access
- Framing the Conversation
- Preparing Patients for a HCT Consultation
- Resources for Patients and Practitioners
Accreditation, Support and Credit
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc., and National Marrow Donor Program/Be The Match. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour and no contact hour in the area of pharmacology.
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Support Statement
There is no commercial support associated with this CE activity.
Disclosure & Conflict of Interest Policy
Medical Learning Institute, Inc. and National Marrow Donor Program/Be The Match are committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.
Faculty Disclosures
Planner
David Hermel, MD
Scripps Clinic
La Jolla, CA, USA
David Hermel, MD, has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Planner
Catherine Lee, MD
University of Utah, Huntsman Cancer Institute
Salt Lake City, UT, USA
Catherine Lee, MD, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Incyte Corporation, Kadmon, Kite Pharma
Research Grant: Incyte Corporation
Speakers’ Bureau: Kite Pharma
The following relationships have ended within the last 24 months:
Advisory Board/Consultant: Bristol Myers Squibb, Fresenius Kabi
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, and National Marrow Donor Program/Be The Match, the joint provider, do not have any relevant financial relationships to disclose with ineligible companies unless listed below.
Steven Devine, MD, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Magenta, Inc., Orca Bio, Sanofi
Heather Stefanski, MD, PhD, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Novartis
All of the relevant financial relationships of individuals for this activity have been mitigated.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. You will receive your certificate from Medical Learning Institute, Inc.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
If you have questions regarding your certificate, please contact Mary Vu via email at mvu@mlieducation.org
About this Activity
Medical Learning Institute, Inc. and National Marrow Donor Program/Be The Match are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.
Copyright © 2023 Medical Learning Institute, Inc. All Rights Reserved.
Resources
Download the course resources from within the presentation lesson.